SCHEMBL10069189

SCHEMBL10069189

CCOP(=O)(OCC)c1ccccc1OCCCOc1ccccc1P(=O)(OCC)OCC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.59
▸ POLB P06746 4/20 0.53
▸ NPC1 O15118 2/20 0.53
▸ PTK2B Q14289 2/20 0.53
▸ HIF1A Q16665 1/20 0.50
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ RAB9A P51151 2/20 0.47
▸ L3MBTL1 Q9Y468 5/20 0.42
▸ MAPT P10636 4/20 0.42
▸ NPSR1 Q6W5P4 2/20 0.42
▸ HPGD P15428 2/20 0.41
▸ ATM Q13315 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ ALPG P10696 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10040019 0.92 ALDH1A1 (0.52) ALDH1A1POLBNPC1PTK2BHIF1A
SCHEMBL8752544 0.82 KMT2A (0.51) ALDH1A1POLBMEN1KMT2AL3MBTL1
SCHEMBL18486629 0.81 MEN1 (0.61) ALDH1A1POLBMEN1KMT2ANPSR1
SCHEMBL10796240 0.78 HIF1A (0.59) ALDH1A1POLBNPC1PTK2BHIF1A
SCHEMBL17488973 0.74 ALDH1A1 (1.00) ALDH1A1POLBNPC1PTK2BHIF1A
SCHEMBL31482562 0.74 KMT2A (0.54) ALDH1A1POLBMEN1KMT2AL3MBTL1
SCHEMBL4455340 0.74 MEN1 (0.54) ALDH1A1POLBMEN1KMT2AL3MBTL1
SCHEMBL3890445 0.74 KMT2A (0.54) ALDH1A1POLBMEN1KMT2AL3MBTL1
SCHEMBL10039996 0.74 PTK2B (0.89) ALDH1A1POLBNPC1PTK2BHIF1A
SCHEMBL780087 0.73 MEN1 (0.53) ALDH1A1POLBMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3251677-A2 PHOSPHATE MANAGEMENT WITH SMALL MOLECULES OPKO Ireland Global Holdings, Limited (IE) 2017-12-06 — — EP disclosed
EP-2389183-B1 PHOSPHATE MANAGEMENT WITH SMALL MOLECULES OPKO IRELAND GLOBAL HOLDINGS LTD (IE) 2017-05-31 — — EP disclosed
US-9198923-B2 Phosphate management with small molecules Opko Ireland Global Holdings, Ltd. (KY) 2015-12-01 — — US disclosed
US-20120028926-A1 Phosphate Management with Small Molecules CYTOCHROMA INC. (CA) 2012-02-02 — — US disclosed
WO-2010083613-A1 PHOSPHATE MANAGEMENT WITH SMALL MOLECULES CYTOCHROMA INC. (CA) 2010-07-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028926-A1 Phosphate Management with Small Molecules SLC34A2, PHPT1, SLC34A3 ALDH1A1 3931/4885POLB 1771/4885NPC1 407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback